Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Buffalo, New York 14202


Purpose:

This study will evaluate the amount of the cholesterol-lowering drug atorvastatin available in the bloodstream, when taken together with the anti-seizure drugs lamotrigine or phenytoin.


Criteria:

Key Inclusion Criteria: - Body weight >50kg (men) or >45kg (women) and BMI within the range 19-32 kg/m2 inclusive. - No clinically significant abnormality on clinical examination Key Exclusion Criteria: - History or evidence of drug or alcohol abuse or active tobacco use. - Women of childbearing potential - Use of prescribed or non-prescribed medications during and within 14 days of starting study medication.


NCT ID:

NCT00627575


Primary Contact:

Study Director
GSK Clinical Trials
GlaxoSmithKline


Backup Contact:

N/A


Location Contact:

Buffalo, New York 14202
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 17, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.